Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05981196 · ClinicalTrials.gov registry record
Disparities Among Liver Transplant Patients
A clinical trial of End Stage Liver DIsease, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05981196 is a study of End Stage Liver DIsease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 485-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05981196, a study of End Stage Liver DIsease, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
Conditions Studied
Study Locations (1)
Arizona
- Mayo Clinic Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-11-15 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05981196
The ClinicalTrials.gov registry entry for NCT05981196 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 485-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (79% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with End Stage Liver DIsease appearing as the primary indexed condition, and to 0 interventions.
NCT05981196 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT05981196 about?
NCT05981196 is a clinical study titled "Disparities Among Liver Transplant Patients". The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
What is the current status of trial NCT05981196?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-11-15. Estimated completion is 2026-07.
What conditions does trial NCT05981196 study?
This clinical trial studies the following conditions: End Stage Liver DIsease.
Who is sponsoring clinical trial NCT05981196?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05981196 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Liver DIsease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
Adverse Outcomes and Mortality in Liver Transplant
RECRUITING · NA
-
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
RECRUITING · NA
-
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
RECRUITING · NA
-
A Study of SIPLIZUMAB in AILD and LT Patients
RECRUITING · Phase 1
-
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.